Pharmabiz5h
ACKO launches ambulance-booking feature on app in partnership with Red.Health
ACKO, the tech-first insurer, has added a feature of booking an ambulance on its mobile app. The company said that it aligns with ACKO's vision of becoming a one-stop destination for all protection ...
Pharmabiz8h
Bespak and Medicines Evaluation Unit collaborate to accelerate clinical trials on climate-friendly inhalers
Bespak and Medicines Evaluation Unit collaborate to accelerate clinical trials on climate-friendly inhalers: Holmes Chapel, England Monday, May 6, 2024, 18:00 Hrs [IST] Bespak, a ...
Pharmabiz8h
Lupin receives US FDA approval for travoprost ophthalmic solution USP
Lupin receives US FDA approval for travoprost ophthalmic solution USP: Our Bureau, Mumbai Monday, May 6, 2024, 17:15 Hrs [IST] Global pharma major Lupin Limited (Lupin) announced ...
Pharmabiz9h
Bimini Health Tech launches rebranded Puregraft Serene Breast Implants
Bimini Health Tech launches rebranded Puregraft Serene Breast Implants: Plano, Texas Monday, May 6, 2024, 17:00 Hrs [IST] Bimini Health Tech, a global leader in regenerative thera ...
Pharmabiz10h
Pan-cancer analysis uncovers a new class of promising CAR T–cell immunotherapy targets
Targeting anti-cancer therapy to affect cancer cells but not healthy cells is challenging. For chimeric antigen receptor (CAR) T–cell immunotherapy, where a patient’s own immune cells are ...
Pharmabiz10h
Cipla’s Breathefree initiative works on empowerment across the care continuum this asthma awareness month in May
Cipla’s Breathefree initiative works on empowerement across the care continuum this asthma awareness month in May. The significance of effective asthma management comes into sharp focus amidst the ...
Pharmabiz11h
Ventus Therapeutics’ partner Novo Nordisk doses first participant in phase 1 study of NNC6022-0001, an oral NLRP3 inhibitor
Ventus Therapeutics’ partner Novo Nordisk doses first participant in phase 1 study of NNC6022-0001, an oral NLRP3 inhibitor: Waltham, Massachusetts Monday, May 6, 2024, 15:00 Hr ...
Pharmabiz12h
Vesica Health introduces AssureMDx test to improve bladder cancer detection
Vesica Health introduces AssureMDx test to improve bladder cancer detection: Irvine, California Monday, May 6, 2024, 14:00 Hrs [IST] Vesica Health, Inc., a leading multi-omics liq ...
Pharmabiz13h
New screening trial to save thousands of men’s lives from prostate cancer
New screening trial to save thousands of men’s lives from prostate cancer: United Kingdom Monday, May 6, 2024, 13:00 Hrs [IST] Thousands more men could be saved every year as a ...
Pharmabiz13h
Wistar scientists discover new immunosuppressive mechanism in brain cancer
The Wistar Institute assistant professor Filippo Veglia, Ph.D., and team, have discovered a key mechanism of how glioblastoma — a serious and often fatal brain cancer — suppresses the immune system so ...
Pharmabiz14h
US FDA announces availability of draft guidance on pharmaceutical development for veterinary drug products
US FDA announces availability of draft guidance on pharmaceutical development for veterinary drug products: Rockville, Maryland Monday, May 6, 2024, 12:00 Hrs [IST] The US Food an ...
Pharmabiz15h
Bespak, H&T Presspart ink collaboration to advance transition to low GWP propellants in pressurised Metered Dose Inhalers
Bespak, H&T Presspart ink collaboration to advance transition to low GWP propellants in pressurised Metered Dose Inhalers: Holmes Chapel, UK Monday, May 6, 2024, 11:00 Hrs [IST] B ...